Education
About Us
Working with TipRanks
Follow Us
Alphamab Oncology (HK:9966)
:9966
Comparison Results
Ascletis Pharma, Inc.
HK$10.68
HK$10.88B
―
968.00%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$15.36
HK$13.54B
20.78
1138.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.65
HK$14.22B
―
161.09%
0 Buy
0 Hold
0 Sell
Hold
Abbisko Cayman Limited
HK$17.45
HK$11.45B
62.49
464.72%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:9966
Alphamab Oncology
11.75
9.09
341.73%
HK:1672
Ascletis Pharma, Inc.
10.68
9.68
968.00%
HK:2142
HBM Holdings Ltd.
15.36
14.12
1138.71%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.65
4.55
146.77%
HK:2256
Abbisko Cayman Limited
17.45
14.33
459.29%
HK:3681
SinoMab Bioscience Ltd.
1.92
0.69
56.10%